Star Equity Holdings Inc Ordinary Shares STRR 深 沪
等待开盘 07-31 09:30:00 美东时间
2.10
0.000
0.00%
华盛通- 最 高2.135
- 今 开2.1327
- 成交量 1.93万股
- 最 低 2.10
- 昨 收 2.10
- 总市值 673.95万
- 52周最高 4.74
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.72
- 委 比 1.53%
- 总股本 320.93万
- 历史最高 314.75
- 量 比 0.63
- 振 幅 1.67%
- 历史最低 1.72
- 每 手 1
- 风险率 0.89%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FL, ENZB, HSON on Behalf of Shareholders
NEW YORK, July 28, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
07-29 06:37
Hudson RPO acquires Alpha Consulting Group Japan
Hudson Global (NASDAQ:HSON) announced on Wednesday the acquisition of Alpha Consulting Group, a Japan-based provider of recruitment services to various companies. Entrance into the Japanese market re...
07-23 21:25
Hudson Global Announces Merger with Star Equity Holdings
Hudson Global ( ($HSON) ) just unveiled an announcement. On May 21, 2025, Hudso...
07-23 04:46
美股大行评级 | 潜在涨幅2840.31%！Mersana Therapeutics获Truist Securities升目标价至10美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130419824951111681.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Truist Securities：维持Mersana Therapeutics(MRSN)"买入"评级，目标价从9美元升至10美元</p> <p>• Guggenheim：维持Cabaletta Bio(CABA)"买入
05-17 08:44
美股大行评级 | 潜在涨幅1281.22%！Cabaletta Bio获Guggenheim升目标价至25美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130057143861719040.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Cabaletta Bio(CABA)"买入"评级，目标价从23美元升至25美元</p> <p>• 瑞穗：维持Tectonic Therapeutic(TECX)"跑赢大市"评级，目标价从51美元
05-16 08:43
Maxim Group Maintains Buy on Star Equity Hldgs, Lowers Price Target to $5
Maxim Group analyst Tate Sullivan maintains Star Equity Hldgs (NASDAQ:STRR) with a Buy and lowers the price target from $8 to $5.
05-16 01:11
Star Equity Holdings shares are trading higher following Q1 reported financial results.
Star Equity Holdings shares are trading higher following Q1 reported financial ...
05-14 21:21
Earnings Scheduled For May 14, 2025
Companies Reporting Before The Bell • Cellebrite DI (NASDAQ:CLBT) is expected t...
05-14 16:32
Star Royalties Adjusts Strategy Amid Carbon Market Challenges
An update from Star Royalties ( ($TSE:STRR) ) is now available. Star Royalties ...
04-28 19:53
Silver Crown Royalties Closes Second Tranche of Private Placement
The latest announcement is out from Star Royalties ( ($TSE:STRR) ). Silver Crow...
03-31 16:03
